J&J Vaccine and Blood Clots: A Risk, if It Exists, Is Tiny
On Tuesday morning, U.S. federal health regulators recommended a pause in the use of Johnson & Johnson’s Covid-19 vaccine while they investigated six reports of blood clots in women ages 18 to 48. One has died, and a second is hospitalized in critical condition. As of Tuesday, 7.2 million people in the United States had…